Abstract #0968
Multiparametric MR imaging for the assessment of prostate cancer aggressiveness at 3 Tesla
Eline K. Vos 1 , Thiele Kobus 1 , Geert Litjens 1 , Thomas Hambrock 1 , Christina Hulsbergen-van de Kaa 2 , Marnix Maas 1 , and Tom Scheenen 1
1
Radiology, Radboud university medical
center, Nijmegen, Gelderland, Netherlands,
2
Pathology,
Radboud university medical center, Nijmegen, Gelderland,
Netherlands
Multiparametric MRI (mpMRI) was evaluated for the
assessment of prostate cancer aggressiveness. For the
peripheral zone only the ADC calculated from DWI should
be used in combination with anatomical T2-weighted
imaging. In the transition zone, both pharmacokinetic
parameters (Ktrans and Kep) derived from DCE-MRI and
metabolite ratios (CC/C and C/C) from MRSI may be useful
additions to T2-weighted imaging and DWI for the
discrimination of indolent versus significant PCa
This abstract and the presentation materials are available to members only;
a login is required.
Join Here
